Andy J Minn MD
Assistant Professor, Radiation Oncology, Perelman School of Medicine
Join to View Full Profile
3400 Civic Center BlvdTRC 2 WestPhiladelphia, PA 19104
Phone+1 215-662-2428
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Andy Minn, MD is a radiation oncologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, New Jersey, and Illinois. He is an Assistant Professor at Perelman School of Medicine.
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2001 - 2005
Louis A Weiss Memorial HospitalInternship, Internal Medicine, 2000 - 2001
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2000
Certifications & Licensure
PA State Medical License 2010 - 2026
NJ State Medical License 2011 - 2015
IL State Medical License 2000 - 2011
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 9 citationsFLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy.Haiwei Ni, Zachary J Reitman, Wei Zou, Md Naushad Akhtar, Ritama Paul
Nature Cancer. 2025-03-01 - 3 citationsTargeting peptide antigens using a multiallelic MHC I-binding system.Haotian Du, Leena Mallik, Daniel Hwang, Yi Sun, Chengzi Kaku
Nature Biotechnology. 2024-12-13 - 3 citationsRecovery of biological signals lost in single-cell batch integration with CellANOVA.Zhaojun Zhang, Divij Mathew, Tristan L Lim, Kaishu Mason, Clara Morral Martinez
Nature Biotechnology. 2024-11-26
Press Mentions
Funded for Success: Dispatch Bio Secures $216M for Cancer InnovationJuly 24th, 2025- How ‘Inflammaging’ Drives Cancer—and Points to New TreatmentsJune 3rd, 2025
- Drug Combo JAKs up Immunotherapy in Two Clinical TrialsAugust 8th, 2024
- Join now to see all
